ProPhase Labs Inc (PRPH)
5.03
-0.08
(-1.57%)
USD |
NASDAQ |
May 17, 16:00
5.02
-0.01
(-0.20%)
Pre-Market: 20:00
ProPhase Labs Revenue (Annual): 44.38M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 44.38M |
| December 31, 2022 | 122.65M |
| December 31, 2021 | 79.04M |
| December 31, 2020 | 14.51M |
| December 31, 2019 | 9.876M |
| December 31, 2018 | 13.13M |
| December 31, 2017 | 9.867M |
| December 31, 2016 | 4.206M |
| December 31, 2015 | 2.518M |
| December 31, 2014 | 22.07M |
| December 31, 2013 | 25.03M |
| December 31, 2012 | 22.41M |
| December 31, 2011 | 17.45M |
| December 31, 2010 | 14.50M |
| Date | Value |
|---|---|
| December 31, 2009 | 19.82M |
| December 31, 2008 | 20.51M |
| December 31, 2007 | 28.24M |
| December 31, 2006 | 26.85M |
| December 31, 2005 | 53.66M |
| December 31, 2004 | 43.95M |
| December 31, 2003 | 41.50M |
| December 31, 2002 | 29.42M |
| December 31, 2001 | 22.77M |
| December 31, 2000 | 15.53M |
| December 31, 1999 | 24.82M |
| December 31, 1998 | 36.35M |
| December 31, 1997 | 70.20M |
| December 31, 1996 | 0.80M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
9.876M
Minimum
2019
122.65M
Maximum
2022
54.09M
Average
44.38M
Median
2023
Revenue (Annual) Benchmarks
| Fonar Corp | 98.65M |
| XWELL Inc | 30.11M |
| Applied DNA Sciences Inc | 13.37M |
| Veracyte Inc | 361.05M |
| OncoCyte Corp | 1.503M |